MLTX Investor with Losses Encourages to Contact Firm by Dec. 15 Deadline Global plaintiffs' rights law firm Hagens Berman reminds investors that the deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit against MoonLake Immunotherapeutics, Inc. (NASDAQ: MLTX) is December 15, 2025. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg “In specialized biotech cases, the […]

CarMax, Inc. (KMX) Investors are Encouraged to Act before the Upcoming January 2 Securities Fraud Deadline – Contact BFA Law if You Lost Money GlobeNewswire December 05, 2025 NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against

Securities Class Action Pending Over Key Drug's Efficacy Global plaintiffs' rights law firm Hagens Berman reminds investors of the December 8, 2025, deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit filed against aTyr Pharma, Inc. (NASDAQ: ATYR). The litigation follows a catastrophic 83% single-day stock collapse after

DUBAI, United Arab Emirates, Dec. 05, 2025 (GLOBE NEWSWIRE) — A rising DeFi project is drawing attention as development progress continues at a steady pace. Mutuum Finance (MUTM), a new DeFi crypto token that has been gaining visibility across investor communities, is moving closer to one of its most important milestones. With its V1 release

New Crypto Mutuum Finance (MUTM) Nears $19.5M in Funding as V1 Q4 Timeline Remains on Track GlobeNewswire December 05, 2025 DUBAI, United Arab Emirates, Dec. 05, 2025 (GLOBE NEWSWIRE) — A rising DeFi project is drawing attention as development progress continues at a steady pace. Mutuum Finance (MUTM), a new DeFi crypto token that has

U.S. FDA grants waiver of application fee for BLA Filing of OST-HER2 Scheduled pre-Marketing Authorisation Application meeting with United Kingdom’s Medicines and Healthcare products Regulatory Agency on December 8, 2025 Scheduled Type C Meeting with United States Food & Drug Administration on December 11, 2025 New York, New York–(Newsfile Corp. – December 5, 2025) –

(NASDAQ:XBP), IRVING, Texas, Dec. 05, 2025 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a global leader in workflow automation and digital transformation, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock. The reverse split will become effective at

Boca Raton, Florida–(Newsfile Corp. – December 5, 2025) – Atlas Lithium Corporation (NASDAQ: ATLX) (“Atlas Lithium” or “Company”), a leading lithium development company advancing Brazil’s premier hard-rock lithium project, today announced that it has entered into securities purchase agreements with two new long term U.S. institutional investors for the purchase and sale of 2,500,000 shares

Vancouver, British Columbia–(Newsfile Corp. – December 5, 2025) – Aegis Critical Energy Defence Corp. (CSE: QESS) (OTCQB: QESSF) (FSE: JG6) (“Aegis” or the “Company”) is pleased to announce that its common shares will begin trading on the OTCQB Venture Market under the new symbol “QESSF” effective December 5, 2025. The updated OTCQB symbol brings all

Vancouver, British Columbia–(Newsfile Corp. – December 5, 2025) – Nexcel Metals Corp. (CSE: NEXX) (OTCQB: NXXCF) (FSE: 2OH) (“Nexcel” or the “Company“) is pleased to announce, further to its news releases dated November 7, 2025 and November 21, 2025, that it has closed its non-brokered private placement (the “Private Placement“) for aggregate gross proceeds of